Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression.
暂无分享,去创建一个
Vitali Alexeev | Jouni Uitto | Jason B. Lee | J. Uitto | Jason B Lee | O. Igoucheva | V. Alexeev | M. El-Domyati | Ahmed F Rezk | Daria Marley Kemp | Moetaz El-Domyati | Wael Hosam El-Din | Olga Igoucheva | W. H. El-Din | D. M. Kemp | A. Rezk
[1] A. Offidani,et al. CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept , 2007, The British journal of dermatology.
[2] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[3] R. Boissy,et al. A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo. , 2006, The American journal of pathology.
[4] Koichiro Nakamura,et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. , 2003, The Journal of allergy and clinical immunology.
[5] J. Cyster,et al. Leukocyte migration: Scent of the T zone , 2000, Current Biology.
[6] U. Kisa,et al. Increased tumor necrosis factor alpha (TNF‐α) and interleukin 1 alpha (IL1‐α) levels in the lesional skin of patients with nonsegmental vitiligo , 2006 .
[7] J. Vestbo,et al. CD8 chemokine receptors in chronic obstructive pulmonary disease , 2008, Clinical and experimental immunology.
[8] H. Soto,et al. CCL27–CCR10 interactions regulate T cell–mediated skin inflammation , 2002, Nature Medicine.
[9] N. J. Gibbons,et al. Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress. , 2004, The Journal of investigative dermatology.
[10] D. Bani,et al. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. , 2009, Histology and histopathology.
[11] J. Hanna,et al. Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. , 2003, Blood.
[12] S. Nishikawa,et al. Murine Cutaneous Mastocytosis and Epidermal Melanocytosis Induced by Keratinocyte Expression of Transgenic Stem Cell Factor , 1998, The Journal of experimental medicine.
[13] D. Bennett,et al. A line of non‐tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth , 1987, International journal of cancer.
[14] H. Kolb,et al. Expression and Secretion of RANTES (CCL5) in Human Adipocytes in Response to Immunological Stimuli and Hypoxia , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[15] R. M. van den Wijngaard,et al. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. , 2001, Trends in immunology.
[16] T. Bieber,et al. IP10/CXCL10 - CXCR3 interaction: a potential self-recruiting mechanism for cytotoxic lymphocytes in lichen sclerosus et atrophicus. , 2007, Acta dermato-venereologica.
[17] M. Juan,et al. One-tube-PCR technique for CCL2, CCL3, CCL4 and CCL5 applied to fine needle aspiration biopsies shows different profiles in autoimmune and non-autoimmune thyroid disorders , 2006, Journal of endocrinological investigation.
[18] H. Mitsui,et al. CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis , 2013, The Journal of investigative dermatology.
[19] V. Sehgal,et al. Vitiligo: Auto‐immunity and immune responses , 2006, International journal of dermatology.
[20] Y. Abiko,et al. Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[21] C. Brosnan,et al. Regulation of RANTES/CCL5 expression in human astrocytes by interleukin‐1 and interferon‐β , 2004, Journal of neurochemistry.
[22] M. Namazi. Statins: novel additions to the dermatologic arsenal? , 2004, Experimental dermatology.
[23] J. V. Stein,et al. Chemokine control of lymphocyte trafficking: a general overview , 2005, Immunology.
[24] Ido D. Weiss,et al. Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. , 2006, The Journal of investigative dermatology.
[25] P. Ghezzi,et al. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. , 1991, Cytokine.
[26] M. Shigemori,et al. Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas. , 2009, International journal of oncology.
[27] M. Picardo,et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference , 2012, Pigment cell & melanoma research.
[28] S. Woo,et al. Distinct locomotive patterns of granulocytes, monocytes and lymphocytes in a stable concentration gradient of chemokines , 2008, International journal of laboratory hematology.
[29] N. J. Gibbons,et al. Methionine sulfoxide reductases A and B are deactivated by hydrogen peroxide (H2O2) in the epidermis of patients with vitiligo. , 2008, The Journal of investigative dermatology.
[30] S. Orlow,et al. Vitiligo inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8 , 2012, The Journal of investigative dermatology.
[31] S. Meller,et al. Socioeconomic factors in lupus erythematosus. , 2005, Autoimmunity reviews.
[32] C. Hunter,et al. CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo , 2014, Science Translational Medicine.
[33] R. Spritz. Modern vitiligo genetics sheds new light on an ancient disease , 2013, The Journal of dermatology.
[34] K. Yoon,et al. Gene correction by RNA-DNA oligonucleotides. , 2000, Pigment cell research.
[35] G. Babcock,et al. PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum , 2000, In Vitro Cellular & Developmental Biology - Animal.
[36] V. Alexeev,et al. Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. , 2006, The Journal of investigative dermatology.
[37] R. Steinman,et al. Expression of a Functional Eotaxin (CC Chemokine Ligand 11) Receptor CCR3 by Human Dendritic Cells1 2 3 , 2002, The Journal of Immunology.
[38] L. Juliano,et al. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice , 2008, Journal of Neuroinflammation.
[39] G. Nilsson,et al. Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. , 2002, Biochemical and biophysical research communications.
[40] O. Igoucheva,et al. Chemokine-enhanced DNA vaccination in cancer immunotherapy , 2013, Oncoimmunology.
[41] O. Igoucheva,et al. Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication , 2007, Molecular Cancer Therapeutics.